Precision Net Debt from 2010 to 2026
| DTIL Stock | USD 4.07 0.31 8.24% |
Net Debt | First Reported 2018-12-31 | Previous Quarter -32.8 M | Current Value -15.7 M | Quarterly Volatility 53.2 M |
Check Precision BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precision BioSciences' main balance sheet or income statement drivers, such as Interest Income of 8.2 M, Depreciation And Amortization of 6.3 M or Interest Expense of 2.2 M, as well as many indicators such as Price To Sales Ratio of 0.41, Dividend Yield of 0.0 or PTB Ratio of 0.44. Precision financial statements analysis is a perfect complement when working with Precision BioSciences Valuation or Volatility modules.
Precision | Net Debt | Build AI portfolio with Precision Stock |
Historical Net Debt data for Precision BioSciences serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Precision BioSciences represents a compelling investment opportunity.
Latest Precision BioSciences' Net Debt Growth Pattern
Below is the plot of the Net Debt of Precision BioSciences over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Precision BioSciences' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Precision BioSciences' overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Precision Net Debt Regression Statistics
| Arithmetic Mean | (97,189,812) | |
| Coefficient Of Variation | (34.90) | |
| Mean Deviation | 22,880,677 | |
| Median | (93,423,000) | |
| Standard Deviation | 33,915,576 | |
| Sample Variance | 1150.3T | |
| Range | 125M | |
| R-Value | 0.07 | |
| Mean Square Error | 1221.7T | |
| R-Squared | 0 | |
| Significance | 0.80 | |
| Slope | 440,443 | |
| Total Sum of Squares | 18404.3T |
Precision Net Debt History
Other Fundumenentals of Precision BioSciences
Precision BioSciences Net Debt component correlations
Click cells to compare fundamentals
About Precision BioSciences Financial Statements
Precision BioSciences investors utilize fundamental indicators, such as Net Debt, to predict how Precision Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Debt | -64.2 M | -67.4 M | |
| Net Debt To EBITDA | (4.75) | (4.51) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Precision BioSciences Correlation against competitors. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. Projected growth potential of Precision fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Precision BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (8.96) | Revenue Per Share | Quarterly Revenue Growth (0.98) | Return On Assets | Return On Equity |
Precision BioSciences's market price often diverges from its book value, the accounting figure shown on Precision's balance sheet. Smart investors calculate Precision BioSciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Precision BioSciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Precision BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precision BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.